ChemoCentryx Announces Appointment of Health Care Insurance Executive Ira Klein, MD, to Company’s Board of Directors


of   Ira , MD, to Company’s of

MOUNTAIN VIEW, Calif., May 28, 2013 (GLOBE NEWSWIRE) — ChemoCentryx, Inc. (Nasdaq:CCXI) has announced the appointment of Ira Klein, MD, MBA, FACP, to its Board of Directors. Most recently the Chief of Staff to the Chief Medical Officer (CMO) at Aetna, Dr. Klein has been newly appointed as National Medical Director, Clinical Thought Leadership to that organization. At Aetna, Dr. Klein is responsible for promoting the strategic efforts of the office of the CMO, including creating and deploying clinical programs, and facilitating integration and clinician development.

“Given the rising importance of payer collaboration with the biopharmaceutical industry, we are delighted to welcome Dr. Klein to the ChemoCentryx board,” said Thomas J. Schall, PhD, President and Chief Executive Officer of ChemoCentryx. “His deep experience in the health care industry and his ability to bring the payer’s perspective to our board will be significant as we advance multiple compounds through clinical development and plan for commercialization.”

Dr. Klein joined Aetna in 2006 as Medical Director and has held various roles in benefit design, financial and clinical analytics, and oncology strategy. Prior to joining Aetna, Dr. Klein was the Medical Director for quality and case management at Bayshore Community Health System in New Jersey. Before that, he served as the Chief Medical Officer of Elderplan, an 11,000-member Medicare Social HMO focused on the frail elderly.

Dr. Klein is a Clinical Assistant Professor of Medicine at the University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, where he also received his medical degree with highest honors. He completed his residency in internal medicine at Brown University and Robert Wood Johnson University Hospital.

About ChemoCentryx

ChemoCentryx, Inc…Read more

Pharmalive – The Pulse of the Pharmaceutical Industry

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS